Literature DB >> 10683325

The HTLV receptor is a widely expressed protein.

S R Trejo1, L Ratner.   

Abstract

The receptor for human T-cell leukemia virus type 1 (HTLV-1) was found to be expressed on a broad range of cell lines derived from multiple species. Receptor expression was assessed using human immunodeficiency virus type 1 particles, pseudotyped with the HTLV-1 envelope glycoprotein, and expressing luciferase under the control of an SV40 enhancer and promoter. Infection by pseudotyped virus was blocked with neutralizing antibodies to HTLV-1, and infection was dependent on the presence of the cleavage and fusogenic sequences in the envelope protein precursor. Trypsin treatment of susceptible target lymphocytes reduced entry. Entry was partially resistant to ammonium chloride. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10683325     DOI: 10.1006/viro.2000.0143

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  27 in total

Review 1.  Neuroimmunity of HTLV-I Infection.

Authors:  Eiji Matsuura; Yoshihisa Yamano; Steven Jacobson
Journal:  J Neuroimmune Pharmacol       Date:  2010-05-02       Impact factor: 4.147

Review 2.  Tetraspanins in viral infections: a fundamental role in viral biology?

Authors:  F Martin; D M Roth; D A Jans; C W Pouton; L J Partridge; P N Monk; G W Moseley
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

3.  Heparan sulfate proteoglycans mediate attachment and entry of human T-cell leukemia virus type 1 virions into CD4+ T cells.

Authors:  Kathryn S Jones; Cari Petrow-Sadowski; Daniel C Bertolette; Ying Huang; Francis W Ruscetti
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

4.  Evidence for common structural determinants of human immunodeficiency virus type 1 coreceptor activity provided through functional analysis of CCR5/CXCR4 chimeric coreceptors.

Authors:  S Pontow; L Ratner
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

5.  Functional murine leukemia virus vectors pseudotyped with the visna virus envelope show expanded visna virus cell tropism.

Authors:  L Bruett; J E Clements
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

6.  Conformation-specific antibodies targeting the trimer-of-hairpins motif of the human T-cell leukemia virus type 1 transmembrane glycoprotein recognize the viral envelope but fail to neutralize viral entry.

Authors:  Antonis Mirsaliotis; Kulpash Nurkiyanova; Daniel Lamb; Jenny M Woof; David W Brighty
Journal:  J Virol       Date:  2007-03-21       Impact factor: 5.103

7.  Cholesterol dependence of HTLV-I infection.

Authors:  Matthew M Wielgosz; Daniel A Rauch; Kathryn S Jones; Frank W Ruscetti; Lee Ratner
Journal:  AIDS Res Hum Retroviruses       Date:  2005-01       Impact factor: 2.205

Review 8.  Pathogenesis and treatment of human T-cell leukemia virus infection.

Authors:  Lee Ratner
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

9.  Human T-cell leukemia virus type 1 blunts signaling by interferon alpha.

Authors:  Xuan Feng; Lee Ratner
Journal:  Virology       Date:  2008-01-29       Impact factor: 3.616

10.  Human T-cell leukemia virus type 1 envelope glycoprotein gp46 interacts with cell surface heparan sulfate proteoglycans.

Authors:  Josefina D Piñon; P J Klasse; Sushma R Jassal; Sandy Welson; Jonathan Weber; David W Brighty; Quentin J Sattentau
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.